TY  - GEN
AU  - Recht,M
AU  - Nemes,L
AU  - Matysiak,M
AU  - Manco-Johnson,M
AU  - Lusher,J
AU  - Smith,M
AU  - Mannucci,P
AU  - Hay,C
AU  - Abshire,T
AU  - O'Brien,A
AU  - Hayward,B
AU  - Udata,C
AU  - Roth,D A
AU  - Arkin,S
TI  - Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII
SN  - 1365-2516
PY  - 2010///0308
KW  - Adolescent
KW  - Adult
KW  - Bayes Theorem
KW  - Blood Coagulation Factor Inhibitors
KW  - genetics
KW  - Child
KW  - Factor VIII
KW  - Hemophilia A
KW  - drug therapy
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Peptide Fragments
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2516.2009.02027.x
ER  -